UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 9 Issue 6
June-2022
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2206733


Registration ID:
404825

Page Number

h280-h291

Share This Article


Jetir RMS

Title

Analytical Method Development and Validation of Rp-hplc Method for Simultaneous Estimation of Ipratropium Bromide and Levosalbutamol in Combined Dosage Formulation.

Abstract

A reverse phase high performance liquid chromatography (RP-HPLC) method for the simultaneous estimation of Ipratropium Bromide and Levosalbutamol in combined pharmaceutical formulation is developed. A Chromatographic separation carried out at 30oc temperature on Agilent Zorbax SB-Aq (250 x 4.6 mm, 5 µ) column. Mobile phase consist of Acetonitrile: 0.1 % Perchloric acid (50:50, % v/v) with flow rate 0.8ml/min and the injection volume was 10 μl. The detection was done by Uv detector at 220nm and the run time was kept 7 min. Acetonitrile: Water (50:50, % v/v) used as a diluent. The retention time for Ipratropium Bromide and Levosalbutamol was at 4.14 and 3.03 respectively. The linearity range for Ipratropium Bromide and Levosalbutamol is 12-18 µg/ml and 36-54 µg/ml. The %RSD for accuracy was found to be less than 2%. High recovery of Ipratropium Bromide (98.8-100.1%) and Levosalbutamol (99.8-101.7%) indicates accuracy of the method. Validation parameters such as accuracy, linearity, precision, system suitability are considered as per International Conference on Harmonization guidelines. Based on all above parameters the proposed method was found to be simple, accurate, precise and reproducible and can be used for simultaneous estimation of Ipratropium Bromide and Levosalbutamol.

Key Words

Ipratropium Bromide, Levosalbutamol, RP-HPLC

Cite This Article

"Analytical Method Development and Validation of Rp-hplc Method for Simultaneous Estimation of Ipratropium Bromide and Levosalbutamol in Combined Dosage Formulation.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 6, page no.h280-h291, June-2022, Available :http://www.jetir.org/papers/JETIR2206733.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Analytical Method Development and Validation of Rp-hplc Method for Simultaneous Estimation of Ipratropium Bromide and Levosalbutamol in Combined Dosage Formulation.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 6, page no. pph280-h291, June-2022, Available at : http://www.jetir.org/papers/JETIR2206733.pdf

Publication Details

Published Paper ID: JETIR2206733
Registration ID: 404825
Published In: Volume 9 | Issue 6 | Year June-2022
DOI (Digital Object Identifier):
Page No: h280-h291
Country: Solapur, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000305

Print This Page

Current Call For Paper

Jetir RMS